The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

ESH 2019 | What's new in flow cytometry assessment of MRD?

Oct 31, 2019

The AML Global Portal were delighted to speak to Jacqueline Cloos, VU University Medical Center, Amsterdam, NL, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Jacqueline Cloos: What's new in flow cytometry assessment of MRD? She discusses how clinically validated MRD can be improved to act as a surrogate end-point in clinical trials.

What's new in flow cytometry assessment of MRD?